Dr. Tarver has been acting director of the CDRH since late July, when Dr. Shuren, who had led the department for nearly 15 years, left the position. She previously served as the deputy director of strategic partnerships and technology innovation, and the program director of patient science and engagement. Dr. Tarver has been with the FDA since 2009.
Patient advocates told The New York Times they hope Dr. Tarver will lead the agency to focus more on safety and less on rapid approvals.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.